XML 32 R20.htm IDEA: XBRL DOCUMENT v3.22.1
Loss Per Common Share
3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Loss Per Common Share Loss Per Common Share
The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):
For the Three Months Ended March 31,
20222021
Loss from continuing operations$(5,350)$(11,190)
Income from discontinued operations, net of tax— 1,383 
Net loss available for common shareholders - basic and diluted$(5,350)$(9,807)
Weighted-average common shares outstanding - basic and diluted89,509 84,670 
Loss per common share
Basic and diluted
Continuing operations$(0.06)$(0.13)
Discontinued operations— 0.01 
Basic and diluted loss per share attributable to common shareholders of Evolent Health, Inc.$(0.06)$(0.12)

Anti-dilutive shares excluded from the calculation of weighted-average common shares presented above are presented below (in thousands):
For the Three Months Ended March 31,
20222021
Restricted stock units ("RSUs"), performance-based RSUs (“PSUs”) and leveraged stock units ("LSUs")2,161 1,531 
Stock options1,756 1,865 
Convertible senior notes11,582 12,696 
Total15,499 16,092